Project Number GC-2012907 Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Year 2016 View Full Project Details for Chiral Switching and Drug Repurposing: Evaluation of (R)-Ricobendazole in the Tau mouse model (rTG4510) of AD Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 4. Non-clinical Drug Development (small molecules and biologics) b. Tau Researcher and Organization Principal Investigator Hodgetts, Kevin Principal Investigator First Name Kevin Principal Investigator Last Name Hodgetts Awardee Organization LDDN Awardee State Massachusetts Contact PI Country United States Project Detail Funding Opportunity Announcement Preclinical RFP FY Overall Cost $153,410 Funding Organization Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Organization Country United States
